Income Statement BioArctic AB

Equities

BIOA B

SE0010323311

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 16/07/2025 pm IST			5-day change	1st Jan Change
189.60 ^SEK	+2.32%		+4.06%	-4.96%

17/06	Lannebo Sverige Plus increased by 4.3 percent in May – rising profitability at Elekta	FW
13/06	BioArctic to Advance Parkinson's Disease Drug Trial After Positive Safety Review	MT

62dd50d849e7b73551c48229181c9436.f3kRCDcfI2MLXo3TKJNO2yJSmAafRoUtm0anmKCbyBM.BwNgT0Z7WltjEPmSYsUc6HA3z1DaDNp72TDg7-vtjnA1D2Ylb0t2BW0Y4g

Published financial data: BIOARCTIC AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	6.23Cr	2.31Cr	23Cr	62Cr	26Cr
Other Revenues, Total	28.61L	25.17L	11.41L	-	-
Total Revenues	6.52Cr	2.57Cr	23Cr	62Cr	26Cr
Cost of Goods Sold, Total	5.02Cr	5.51Cr	7.43Cr	8.96Cr	2.7Cr
Gross Profit	1.5Cr	-2.94Cr	16Cr	53Cr	23Cr
Selling General & Admin Expenses, Total	8.63Cr	9.74Cr	15Cr	25Cr	15Cr
R&D Expenses	-	-	-	-	31Cr
Depreciation & Amortization - (IS)	1.1Cr	1.31Cr	1.46Cr	1.84Cr	-
Other Operating Expenses	-79T	-9T	-3L	-3L	-
Other Operating Expenses, Total	9.73Cr	11Cr	16Cr	27Cr	46Cr
Operating Income	-8.23Cr	-14Cr	-79.38L	26Cr	-23Cr
Interest Expense, Total	-10.98L	-8L	-6L	-3L	-
Interest And Investment Income	7T	-	25.35L	3.42Cr	4.08Cr
Net Interest Expenses	-10.91L	-8L	19.76L	3.39Cr	4.08Cr
Currency Exchange Gains (Loss)	-30.74L	3L	-50.14L	-1.43Cr	-7L
Other Non Operating Income (Expenses)	-2T	-1L	-2L	-50T	1T
EBT, Excl. Unusual Items	-8.65Cr	-14Cr	-1.12Cr	28Cr	-19Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-2L	-8T	-	-	-
EBT, Incl. Unusual Items	-8.67Cr	-14Cr	-1.12Cr	28Cr	-19Cr
Income Tax Expense	-1.82Cr	-2.07Cr	11T	4.72Cr	-1.24Cr
Earnings From Continuing Operations	-6.85Cr	-12Cr	-1.12Cr	23Cr	-18Cr
Net Income to Company	-6.85Cr	-12Cr	-1.12Cr	23Cr	-18Cr
Net Income - (IS)	-6.85Cr	-12Cr	-1.12Cr	23Cr	-18Cr
Net Income to Common Incl Extra Items	-6.85Cr	-12Cr	-1.12Cr	23Cr	-18Cr
Net Income to Common Excl. Extra Items	-6.85Cr	-12Cr	-1.12Cr	23Cr	-18Cr
Per Share Items
Net EPS - Basic	-0.78	-1.36	-0.13	2.6	-2
Basic EPS - Continuing Operations	-0.78	-1.36	-0.13	2.6	-2
Basic Weighted Average Shares Outstanding	8.81Cr	8.81Cr	8.81Cr	8.82Cr	8.83Cr
Net EPS - Diluted	-0.78	-1.36	-0.13	2.59	-2
Diluted EPS - Continuing Operations	-0.78	-1.36	-0.13	2.59	-2
Diluted Weighted Average Shares Outstanding	8.81Cr	8.81Cr	8.87Cr	8.85Cr	8.85Cr
Normalized Basic EPS	-0.61	-1	-0.08	1.96	-1.34
Normalized Diluted EPS	-0.61	-1	-0.08	1.95	-1.34
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	-7.85Cr	-13Cr	-17.66L	28Cr	-21Cr
EBITA	-8.23Cr	-14Cr	-79.38L	26Cr	-23Cr
EBIT	-8.23Cr	-14Cr	-79.38L	26Cr	-23Cr
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	6.59Cr	2.67Cr	23Cr	-62Cr	-
Effective Tax Rate - (Ratio)	20.96	14.75	-0.1	17.08	6.56
Total Current Taxes	-	-	-	3.48Cr	3L
Total Deferred Taxes	-1.82Cr	-2.07Cr	11T	1.24Cr	-1.28Cr
Normalized Net Income	-5.41Cr	-8.78Cr	-69.8L	17Cr	-12Cr
Interest on Long-Term Debt	-	8L	6L	3L	-
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	-	5.55Cr
General and Administrative Expenses	-	-	-	-	9.34Cr
Research And Development Expense From Footnotes	-	-	-	-	31Cr
Net Rental Expense, Total	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	13.19L	15.68L	27.6L	1.61Cr	-
Stock-Based Comp., Other (Total)	-	-	-	-	1.93Cr
Total Stock-Based Compensation	13.19L	15.68L	27.6L	1.61Cr	1.93Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	100Cr	85Cr	81Cr	61Cr	51Cr
Short Term Investments	-	-	-	50Cr	27Cr
Total Cash And Short Term Investments	100Cr	85Cr	81Cr	111.16Cr	78Cr
Accounts Receivable, Total	-	28.39L	-	2L	7.12Cr
Other Receivables	56.01L	62.05L	79.56L	3.15Cr	14Cr
Total Receivables	56.01L	90.44L	79.56L	3.18Cr	21Cr
Prepaid Expenses	28.19L	43.37L	74.98L	94.02L	1.82Cr
Other Current Assets, Total	-	-	1T	-1T	-
Total Current Assets	100.84Cr	86Cr	82Cr	115.27Cr	101.07Cr
Gross Property Plant And Equipment	7.5Cr	8.22Cr	9.79Cr	11Cr	16Cr
Accumulated Depreciation	-3.5Cr	-4.85Cr	-6.27Cr	-7.73Cr	-6.17Cr
Net Property Plant And Equipment	3.99Cr	3.37Cr	3.53Cr	3.11Cr	9.66Cr
Deferred Tax Assets Long-Term	5L	6L	6L	6L	10L
Other Long-Term Assets, Total	15.61L	15.88L	16.06L	16.48L	34.41L
Total Assets	105.03Cr	90Cr	86Cr	118.61Cr	111.17Cr
Liabilities
Accounts Payable, Total	1.43Cr	1.18Cr	2.15Cr	2.99Cr	5.05Cr
Accrued Expenses, Total	1.57Cr	1.83Cr	3.51Cr	4.88Cr	6.83Cr
Current Portion of Leases	71.41L	80.92L	88.57L	28.27L	1.31Cr
Current Income Taxes Payable	-	-	-	3.38Cr	3.36Cr
Unearned Revenue Current, Total	6.8Cr	5.91Cr	-	-	-
Other Current Liabilities	35.77L	39.2L	54.27L	96.65L	1.01Cr
Total Current Liabilities	11Cr	10Cr	7.09Cr	12Cr	18Cr
Long-Term Leases	1.36Cr	77.85L	11.82L	21.52L	4.11Cr
Deferred Tax Liability Non Current	2.07Cr	-	-	1.24Cr	-
Other Non Current Liabilities	-	1T	1T	-	-
Total Liabilities	14Cr	11Cr	7.21Cr	14Cr	22Cr
Common Stock, Total	17.61L	17.61L	17.63L	17.66L	17.68L
Additional Paid In Capital	56Cr	56Cr	57Cr	58Cr	59Cr
Retained Earnings	34Cr	23Cr	22Cr	46Cr	31Cr
Comprehensive Income and Other	10L	10L	10L	10L	10L
Total Common Equity	91Cr	79Cr	79Cr	104.66Cr	89Cr
Minority Interest	-	-	-	-	-
Total Equity	91Cr	79Cr	79Cr	104.66Cr	89Cr
Total Liabilities And Equity	105.03Cr	90Cr	86Cr	118.61Cr	111.17Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.81Cr	8.81Cr	8.81Cr	8.83Cr	8.84Cr
ECS Total Common Shares Outstanding	8.81Cr	8.81Cr	8.81Cr	8.83Cr	8.84Cr
Book Value / Share	10.3	8.96	8.92	11.85	10.13
Tangible Book Value	91Cr	79Cr	79Cr	104.66Cr	89Cr
Tangible Book Value Per Share	10.3	8.96	8.92	11.85	10.13
Total Debt	2.08Cr	1.59Cr	1Cr	49.79L	5.42Cr
Net Debt	-98Cr	-83Cr	-80Cr	-110.66Cr	-72Cr
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	3.56Cr	3.98Cr	5.03Cr	5.71Cr	7.25Cr
Full Time Employees	45	49	61	88	107

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-6.85Cr	-12Cr	-1.12Cr	23Cr	-18Cr
Depreciation & Amortization - CF	1.1Cr	1.35Cr	1.42Cr	74.39L	1.07Cr
Depreciation & Amortization, Total	1.1Cr	1.35Cr	1.42Cr	74.39L	1.07Cr
(Gain) Loss From Sale Of Asset	2L	-	-	-	-
Stock-Based Compensation (CF)	13.19L	15.68L	27.6L	1.61Cr	1.93Cr
Other Operating Activities, Total	-6.29Cr	-3.07Cr	-6.23Cr	4.37Cr	-11Cr
Change In Accounts Receivable	2.31Cr	-51.22L	-24.14L	-1.2Cr	-11Cr
Change in Other Net Operating Assets	34.72L	62T	2.73Cr	2.51Cr	4.27Cr
Cash from Operations	-9.23Cr	-14Cr	-3.16Cr	31Cr	-32Cr
Capital Expenditure	-1.25Cr	-43.86L	-1.27Cr	-74.43L	-2.66Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-51T	-27T	-18T	-50Cr	23Cr
Other Investing Activities, Total	-	1T	1T	-	1T
Cash from Investing	-1.25Cr	-44.12L	-1.28Cr	-51Cr	21Cr
Long-Term Debt Repaid, Total	-65.98L	-73.89L	-87.93L	-9L	-3L
Total Debt Repaid	-65.98L	-73.89L	-87.93L	-9L	-3L
Issuance of Common Stock	-	-	59.85L	1.5Cr	60.16L
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-1T	-1T
Cash from Financing	-65.98L	-73.89L	-28.08L	1.41Cr	56.86L
Foreign Exchange Rate Adjustments	-13.67L	7L	41.9L	-1.01Cr	63.74L
Miscellaneous Cash Flow Adjustments	-	1T	-	1T	-
Net Change in Cash	-11Cr	-15Cr	-4.3Cr	-19Cr	-9.86Cr
Supplemental Items
Cash Interest Paid	16.86L	10L	8L	4L	18.49L
Cash Income Tax Paid (Refund)	1.22Cr	3L	-3L	-2L	5L
Levered Free Cash Flow	-7.03Cr	-9.06Cr	-3.43Cr	21Cr	-29Cr
Unlevered Free Cash Flow	-6.96Cr	-9.01Cr	-3.4Cr	21Cr	-29Cr
Change In Net Working Capital	1.8Cr	1.34Cr	3.32Cr	-3.44Cr	15Cr
Net Debt Issued / Repaid	-65.98L	-73.89L	-87.93L	-9L	-3L

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-4.61	-8.97	-0.56	15.71	-12.49
Return on Total Capital	-5.33	-10.09	-0.62	17.38	-14.35
Return On Equity %	-7.28	-14.13	-1.42	25.02	-18.24
Return on Common Equity	-7.28	-14.13	-1.42	25.02	-18.24
Margin Analysis
Gross Profit Margin %	22.95	-114.58	67.6	85.45	89.51
SG&A Margin	132.42	379.34	64.8	40.79	57.84
EBITDA Margin %	-120.36	-523.12	-0.77	44.71	-82.06
EBITA Margin %	-126.23	-544.96	-3.46	41.71	-89.22
EBIT Margin %	-126.23	-544.96	-3.46	41.71	-89.22
Income From Continuing Operations Margin %	-105.07	-466.78	-4.87	37.22	-68.81
Net Income Margin %	-105.07	-466.78	-4.87	37.22	-68.81
Net Avail. For Common Margin %	-105.07	-466.78	-4.87	37.22	-68.81
Normalized Net Income Margin	-82.89	-342.19	-3.04	28.05	-46.03
Levered Free Cash Flow Margin	-107.78	-353.02	-14.97	34.24	-112.8
Unlevered Free Cash Flow Margin	-106.72	-350.98	-14.81	34.27	-112.8
Asset Turnover
Asset Turnover	0.06	0.03	0.26	0.6	0.22
Fixed Assets Turnover	1.69	0.7	6.65	18.56	4.03
Receivables Turnover (Average Receivables)	-	-	-	-	7.21
Short Term Liquidity
Current Ratio	9.27	8.51	11.58	9.22	5.75
Quick Ratio	9.25	8.47	11.47	9.15	5.65
Operating Cash Flow to Current Liabilities	-0.85	-1.39	-0.45	2.48	-1.8
Days Sales Outstanding (Average Receivables)	-	-	-	-	50.79
Average Days Payable Outstanding	82.06	86.6	81.79	104.58	544.71
Long Term Solvency
Total Debt/Equity	2.29	2.01	1.28	0.48	6.06
Total Debt / Total Capital	2.24	1.97	1.26	0.47	5.71
LT Debt/Equity	1.5	0.99	0.15	0.21	4.59
Long-Term Debt / Total Capital	1.47	0.97	0.15	0.2	4.33
Total Liabilities / Total Assets	13.62	12.15	8.4	11.76	19.5
EBIT / Interest Expense	-74.97	-166.89	-14.2	783.41	-
EBITDA / Interest Expense	-64.94	-150.76	11.17	873.09	-
(EBITDA - Capex) / Interest Expense	-76.3	-155.99	-11.63	850.4	-
Total Debt / EBITDA	-0.29	-0.13	1.61	0.02	-0.27
Net Debt / EBITDA	13.73	6.59	-127.34	-3.86	3.67
Total Debt / (EBITDA - Capex)	-0.25	-0.12	-1.54	0.02	-0.24
Net Debt / (EBITDA - Capex)	11.69	6.37	122.36	-3.97	3.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-76.95	-60.64	794.02	168.49	-58.22
Gross Profit, 1 Yr. Growth %	-92.89	-296.5	-627.5	239.36	-61.67
EBITDA, 1 Yr. Growth %	-168.82	71.04	-98.69	-14.81T	-176.69
EBITA, 1 Yr. Growth %	-174.1	69.9	-94.32	-3.34T	-189.36
EBIT, 1 Yr. Growth %	-174.1	69.9	-94.32	-3.34T	-189.36
Earnings From Cont. Operations, 1 Yr. Growth %	-177.45	74.83	-90.67	-2.15T	-177.24
Net Income, 1 Yr. Growth %	-177.45	74.83	-90.67	-2.15T	-177.24
Normalized Net Income, 1 Yr. Growth %	-176.55	62.47	-92.05	-2.58T	-168.55
Diluted EPS Before Extra, 1 Yr. Growth %	-178	74.4	-90.44	-2.09T	-177.39
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	31.83T
Net Property, Plant and Equip., 1 Yr. Growth %	7.56	-15.5	4.49	-11.73	210.42
Total Assets, 1 Yr. Growth %	-11.24	-14.53	-4.39	38.19	-6.27
Tangible Book Value, 1 Yr. Growth %	-6.9	-13.07	-0.31	33.11	-14.49
Common Equity, 1 Yr. Growth %	-6.9	-13.07	-0.31	33.11	-14.49
Cash From Operations, 1 Yr. Growth %	-128.22	52.11	-77.48	-1.08T	-202.14
Capital Expenditures, 1 Yr. Growth %	282.37	-64.84	190.61	-41.61	257.85
Levered Free Cash Flow, 1 Yr. Growth %	-122.81	29.04	-62.3	-712.39	-237.63
Unlevered Free Cash Flow, 1 Yr. Growth %	-122.53	29.42	-62.46	-719.27	-237.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-69.95	-69.88	87.58	389.93	5.91
Gross Profit, 2 Yr. CAGR %	-83.89	-62.63	221.95	323.1	21.87
EBITDA, 2 Yr. CAGR %	-59.89	8.49	-85	42.97	962.14
EBITA, 2 Yr. CAGR %	-58.84	12.2	-68.95	35.55	437.83
EBIT, 2 Yr. CAGR %	-58.84	12.2	-68.95	35.55	437.83
Earnings From Cont. Operations, 2 Yr. CAGR %	-57.63	16.36	-59.61	38.34	298
Net Income, 2 Yr. CAGR %	-57.63	16.36	-59.61	38.34	298
Normalized Net Income, 2 Yr. CAGR %	-57.97	11.52	-64.06	40.28	311.94
Diluted EPS Before Extra, 2 Yr. CAGR %	-57.56	16.63	-59.18	37.98	292.66
Accounts Receivable, 2 Yr. CAGR %	-	288.6	-	-71.97	-
Net Property, Plant and Equip., 2 Yr. CAGR %	107.36	-4.67	-6.04	-3.96	65.53
Total Assets, 2 Yr. CAGR %	-13.17	-12.9	-9.6	14.94	13.81
Tangible Book Value, 2 Yr. CAGR %	-5.58	-10.04	-6.91	15.2	6.69
Common Equity, 2 Yr. CAGR %	-5.58	-10.04	-6.91	15.2	6.69
Cash From Operations, 2 Yr. CAGR %	-32.06	-34.48	-41.47	48.49	216.21
Capital Expenditures, 2 Yr. CAGR %	71.21	15.96	1.09	30.27	44.56
Levered Free Cash Flow, 2 Yr. CAGR %	-51.61	-45.78	-30.07	52.19	190.32
Unlevered Free Cash Flow, 2 Yr. CAGR %	-51.78	-46	-30.12	52.7	191.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-25.36	-67.12	-6.75	111.4	115.65
Gross Profit, 3 Yr. CAGR %	-45.64	-62.92	-9.68	227.65	98.61
EBITDA, 3 Yr. CAGR %	44.49	-34.96	-75.08	51.95	16.17
EBITA, 3 Yr. CAGR %	50.76	-33.97	-58.5	46.15	17.97
EBIT, 3 Yr. CAGR %	50.76	-33.97	-58.5	46.15	17.97
Earnings From Cont. Operations, 3 Yr. CAGR %	65.35	-32.04	-49.82	49.57	13.92
Net Income, 3 Yr. CAGR %	65.35	-32.04	-49.82	49.57	13.92
Normalized Net Income, 3 Yr. CAGR %	65.55	-34.04	-53.76	47.32	10.49
Diluted EPS Before Extra, 3 Yr. CAGR %	51.87	-32.02	-49.34	49.19	13.79
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	192.7
Net Property, Plant and Equip., 3 Yr. CAGR %	77.91	53.73	-1.71	-7.98	42
Total Assets, 3 Yr. CAGR %	-2.71	-13.62	-10.15	4.14	7.39
Tangible Book Value, 3 Yr. CAGR %	12.56	-8.15	-6.91	4.88	4.3
Common Equity, 3 Yr. CAGR %	12.56	-8.15	-6.91	4.88	4.3
Cash From Operations, 3 Yr. CAGR %	-11.96	-11.12	-54.1	49.69	31.08
Capital Expenditures, 3 Yr. CAGR %	53.51	1.02	57.51	-15.81	82.44
Levered Free Cash Flow, 3 Yr. CAGR %	-21.31	-32.92	-51.88	44.29	47.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	-21.49	-32.98	-52.08	44.76	47.45
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.42	-24.64	7.91	-3.13	-1.88
Gross Profit, 5 Yr. CAGR %	-18.48	-22.53	10.73	-1.82	1.82
EBITDA, 5 Yr. CAGR %	65.3	15.88	-41.61	-10.81	13.11
EBITA, 5 Yr. CAGR %	76.37	17.41	-19.87	-11.96	15.63
EBIT, 5 Yr. CAGR %	76.37	17.41	-19.87	-11.96	15.63
Earnings From Cont. Operations, 5 Yr. CAGR %	79.18	15.78	-5.91	-9.69	14.89
Net Income, 5 Yr. CAGR %	79.18	15.78	-5.91	-9.69	14.89
Normalized Net Income, 5 Yr. CAGR %	78.21	13.64	-10.14	-10.8	10.9
Diluted EPS Before Extra, 5 Yr. CAGR %	67.69	8.3	-10.21	-9.77	14.92
Accounts Receivable, 5 Yr. CAGR %	-	34.96	-	-	227.84
Net Property, Plant and Equip., 5 Yr. CAGR %	56.65	43	37.82	27.36	21.08
Total Assets, 5 Yr. CAGR %	51.61	4.86	-5.53	-3.17	-1.24
Tangible Book Value, 5 Yr. CAGR %	52.98	66.98	4.33	0.56	-1.69
Common Equity, 5 Yr. CAGR %	52.98	66.98	4.33	0.56	-1.69
Cash From Operations, 5 Yr. CAGR %	41.23	-26.95	-25.22	9.13	-0.67
Capital Expenditures, 5 Yr. CAGR %	40.34	8.13	29.89	11.83	52.19
Levered Free Cash Flow, 5 Yr. CAGR %	-	-32.69	-24.95	-6.81	-1.19
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-32.77	-25.06	-6.74	-1.23